Study to compare the effect of fentanyl and dexmedetomidine when added to 0.5% Bupivacaine in brachial plexus block for upper limb surgeries
Not Applicable
- Conditions
- Health Condition 1: S510- Open wound of elbowHealth Condition 2: S529- Unspecified fracture of forearmHealth Condition 3: S629- Unspecified fracture of wrist andhand
- Registration Number
- CTRI/2022/11/047044
- Lead Sponsor
- Madiha Mehmood Ansari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age18 years - 60 years
- ASA grade 1 and 2
- Scheduled for elective upper limb surgeries under supraclavicular brachial plexus
block.
Exclusion Criteria
Lack of patientâ??s consent. - Age <18yrs and >60yrs.- ASA grade 3 and more.
- History of serious pulmonary disease, ischemic heart disease, renal/hepaticdysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile. - Patient with h/o opioid abuse.
- Patients with local skin site infections.
- Patients with hypersensitivity to any of the drugs used.
- Pregnant and lactating mothers.
- Failure of Block
- Restricted neck movement.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of 0.5% Bupivacaine with dexmedetomidine, 0.5% Bupivacaine with fentanyl and 0.5% Bupivacaine innerve stimulator guided supraclavicular brachial plexus block.Timepoint: First 24 hours at 5 mins, 10 mins, 15 mins, 30 mins, 1 hour, 2 hour, 4 hours, 6 hours, 12 hours and 24 hours
- Secondary Outcome Measures
Name Time Method To compare side effects of 0.5% Bupivacaine with dexmedetomidine, 0.5% Bupivacaine with fentanyl and 0.5% Bupivacaine innerve stimulator guided supraclavicular brachial plexus block.Timepoint: First 24 hours at 5 mins, 10 mins, 15 mins, 30 mins, 1 hour, 2 hour, 4 hours, 6 hours, 12 hours and 24 hours